Who
Carl A. Merton
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Tilray Brands.
In numbers
- Trades disclosed
- 102
- Buys
- 4
- Sells
- 1
- Bought
- $185K
- Sold
- $1.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Apr 2021
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —57,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $154K31,559 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —111,072 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —57,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —111,072 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $298K61,090 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —57,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —111,072 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —57,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $154K31,559 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —111,072 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $298K61,090 at $4.88 | filing |
| 4 Aug 2026filed 4 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Bought | $46K10,000 at $4.62 | filing |
| 4 Aug 2026filed 4 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Bought | $46K10,000 at $4.62 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —16,656 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —16,656 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $38K9,161 at $4.20 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —16,656 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —16,656 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $38K9,161 at $4.20 | filing |
News
Head to Head Comparison: Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Tilray Brands (NASDAQ:TLRY)TLRY · tickerreport.com · 24 Oct 2026Comparing Cumberland Pharmaceuticals (NASDAQ:CPIX) and Tilray Brands (NASDAQ:TLRY)TLRY · dailypolitical.com · 24 Oct 2026Tilray Brands, Inc.: West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for HammersTLRY · finanznachrichten.de · 21 Oct 2026
0 headlines in the last 90 days name Carl A. Merton; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.